CME Group and IHS Markit’s joint venture gets approval from UK Antitrust Agency

The joint venture will combine the two companies’ post trade service. IHS Markit’s OTC derivatives and forex trade processing business  will work together with CME Group’s OTC derivatives optimization businesses, operating as Traiana, TriOptima and Reset.

The CMA first opened the investigation in June 2021 over concerns of “lessening of competition within any market or markets in the United Kingdom for goods or services” but has not found any issues.

The latest approval of the joint venture comes days after the European Commission confirmed the joined venture.